Immunoassay Market Report – Research, Industry Analysis Reports and Market Demands

Immunoassay Market to 2027 - Global Analysis and Forecasts By Product (Reagents & kits, Analyzers & Instruments, Software & Services); Technology (Enzyme-Linked Immunosorbent Assays (ELISA), Fluorescence, Chemiluminescence, Rapid Test, Western Blot, Enzyme-Linked Immune Absorbent Spot (ELISPOT), Polymerase Chain Reaction (PCR)); Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Others); End User (Hospitals, Blood banks

Request for Sample of this report

Buy now

Table of Content

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Immunoassay Market – By Product
- 1.3.2 Global Immunoassay Market – By Technology
- 1.3.3 Global Immunoassay Market – By Application
- 1.3.4 Global Immunoassay Market – By End User
- 1.3.5 Global Immunoassay Market – By Geography

2. Global Immunoassay Market – Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Immunoassay Market – Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East & Africa PEST Analysis
- 4.2.5 South & Central America PEST Analysis

5. Global Immunoassay Market – Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Rising Incidences of Chronic and Infectious Diseases
- 5.1.2 Technological Advancements in Immunoassay Devices
- 5.1.3 Growing Biotechnology & Biopharmaceutical Industries
5.2 Key Market Restraints
- 5.2.1 Stringent Regulatory Requirements for Immunoassay Devices
5.3 Key Market Opportunities
- 5.3.1 Development Opportunities in Emerging Countries
5.4 Future Trends
- 5.4.1 Increasing Acceptance of Immunoassay-Based Point-Of-Care Testing
5.5 Impact Analysis

6. Immunoassay Market – Global Analysis

6.1 Global Immunoassay Market Revenue Forecasts And Analysis
6.2 Global Immunoassay Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players

7. Global Immunoassay Market Analysis– by Product

7.1 Overview
7.2 Global Immunoassay Market, By Product 2018 & 2027 (%)
7.3 Reagents & Kits Market
- 7.3.1 Overview
- 7.3.2 Global Reagents & Kits Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Analyzers & Instruments Market
- 7.4.1 Overview
- 7.4.2 Global Analyzers & Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.4.3 Open-Ended Systems Market
  - 7.4.3.1 Overview
  - 7.4.3.2 Global Open-Ended Systems Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.4.4 Closed-Ended Systems Market
  - 7.4.4.1 Overview
  - 7.4.4.2 Global Closed-Ended Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Software & Services Market
- 7.5.1 Overview
- 7.5.2 Global Software & Services Market Revenue and Forecasts to 2027 (US$ Mn)

8. Global Immunoassay Market Analysis– by Technology

8.1 Overview
8.2 Global Immunoassay Market, By Technology 2018 & 2027 (%)
8.3 Enzyme-Linked Immunosorbent Assays (ELISA) Market
- 8.3.1 Overview
- 8.3.2 Global Enzyme-Linked Immunosorbent Assays (ELISA) Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Fluorescence Market
- 8.4.1 Overview
- 8.4.2 Global Fluorescence Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Chemiluminescence Market
- 8.5.1 Overview
- 8.5.2 Global Chemiluminescence Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Rapid Test Market
- 8.6.1 Overview
- 8.6.2 Global Rapid Test Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Western Blot Market
- 8.7.1 Overview
- 8.7.2 Global Western Blot Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Enzyme-Linked Immune Absorbent Spot (ELISPOT) Market
- 8.8.1 Overview
- 8.8.2 Global Enzyme-Linked Immune Absorbent Spot (ELISPOT) Market Revenue and Forecasts to 2027 (US$ Mn)
8.9 Polymerase Chain Reaction (PCR) Market
- 8.9.1 Overview
- 8.9.2 Global Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)

9. Global Immunoassay Market Analysis– by Application

9.1 Overview
9.2 Global Immunoassay Market, By Application 2018 & 2027 (%)
9.3 Therapeutic Drug Monitoring Market
- 9.3.1 Overview
- 9.3.2 Global Therapeutic Drug Monitoring Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Oncology Market
9.4.1.1 Overview
9.4.1.2 Global Oncology Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Cardiology Market

9.5.1 Overview
9.5.2 Global Cardiology Market Revenue and Forecasts to 2027 (US$ Mn)

9.6 Endocrinology Market

9.6.1 Overview
9.6.2 Global Endocrinology Market Revenue and Forecasts to 2027 (US$ Mn)

9.7 Infectious Disease Testing Market

9.7.1 Overview
9.7.2 Global Infectious Disease Testing Market Revenue and Forecasts to 2027 (US$ Mn)

9.8 Autoimmune Diseases Market

9.8.1 Overview
9.8.2 Global Autoimmune Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

9.9 Others Market

9.9.1 Overview
9.9.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. Global Immunoassay Market Analysis– by End User

10.1 Overview
10.2 Global Immunoassay Market, By End User 2018 & 2027 (%)
10.3 Hospitals Market
- 10.3.1 Overview
- 10.3.2 Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Blood Banks Market
- 10.4.1 Overview
- 10.4.2 Global Blood Banks Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Clinical Laboratories Market
- 10.5.1 Overview
- 10.5.2 Global Clinical Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
10.6 Pharmaceutical & Biotech Companies Market
- 10.6.1 Overview
- 10.6.2 Global Pharmaceutical & Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)
10.7 Academic Research Centers Market
- 10.7.1 Overview
- 10.7.2 Global Academic Research Centers Market Revenue and Forecasts to 2027 (US$ Mn)
10.8 Others Market
- 10.8.1 Overview
- 10.8.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

11. Immunoassay Market Revenue and Forecasts to 2027 – Geographical Analysis

Description

The global immunoassay market is expected to reach US$ 37,987.8 Mn in 2027 from US$ 21,800.0 in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027.
The market for immunoassay is expected to grow, owing to factors such as rising incidences of chronic and infectious diseases, technological advancements in immunoassay devices, and growing biotechnology & biopharmaceutical industries have been boosting the market over the years. However, the stringent regulatory requirements for immunoassay devices are likely to have a negative impact on the growth of the market in the coming years.
Immunoassay is used to measure the concentration of small molecules such as lipids, protein, nucleic acids, etc. in solutions using antigen-antibody reactions. It is majorly used to detect several infectious disorders like dengue, hepatitis, human immunodeficiency virus (HIV). Increasing incidences of infectious diseases such as HIV is the primary global public health issue. In 2018, the World Health Organization (WHO) having claimed that more than 32 million HIV people are diagnosed, out of which 770,000 people died. At the end of 2018, around 1.7 million people were reported to be newly infected globally, including 62% of adults and 54% of children. According to the HIV and AIDS organization (AVERT), in 2018, 1.1 million U.S. residents were infected with HIV, whereas APAC registered 5.2 million HIV-infected population. According to the European CDC, ~2 million people in Europe were infected with HIV in 2018. Such an increase in the incidence of chronic and infectious diseases is expected to create a demand for immunoassay tests around the world.
Global immunoassay market is segmented by product, technology, application, end user. On the basis of product, the market is segmented reagents & kits, analyzers & instruments, software & services. On the basis of technology, it is segmented into enzyme-linked immunosorbent assays (ELISA), fluorescence, chemiluminescence, rapid test, western blot, enzyme-linked immune absorbent spot (ELISPOT), polymerase chain reaction (PCR). On the basis of application, the immunoassay market is further segmented into therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, autoimmune diseases, others. Based on end user the market is segmented into hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, academic research centers, others.
Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization, HIV and AIDS organization (AVERT), Center for Disease Control and Prevention (CDC), National Center for Health Statistics, American Heart Association, European Union (E.U.). and others.